Beta Thalassemia Trait Characteristics

Epidemiology and Genetics

The condition is most prevalent in populations from Mediterranean regions, Middle East, Southeast Asia, and Africa—areas with historical endemic malaria exposure, according to the Centers for Disease Control and Prevention 1, 2

Beta thalassemia trait is characterized by microcytic hypochromic anemia that does not respond to iron supplementation, with a mean corpuscular volume (MCV) typically <80 fL and mean corpuscular hemoglobin (MCH) reduced, as reported by the Centers for Disease Control and Prevention 1, 2

The most clinically important characteristic is that mild anemia in beta thalassemia trait does NOT respond to iron supplementation despite compliance with therapy and absence of acute illness, according to the Centers for Disease Control and Prevention 1, 2
This distinguishes it from iron deficiency anemia, which should show hemoglobin increase of 1 g/dL or hematocrit increase of 3% after 4 weeks of adequate iron therapy, as stated by the Centers for Disease Control and Prevention 1, 2

Do not prescribe iron supplementation to patients with confirmed beta thalassemia trait—it provides no benefit and may contribute to unnecessary iron accumulation, as advised by the Centers for Disease Control and Prevention 1, 2
Do not miss the diagnosis in pregnant women of appropriate ancestry who have persistent mild anemia unresponsive to prenatal iron supplementation—further evaluation with MCV, RDW, and hemoglobin electrophoresis is indicated, according to the Centers for Disease Control and Prevention 1, 2
Failure to consider ethnicity in the diagnostic approach leads to missed diagnoses, as beta thalassemia trait is significantly more common in Mediterranean, Middle Eastern, Southeast Asian, and African populations, as reported by the Centers for Disease Control and Prevention 1, 2
When evaluating microcytic anemia, always check serum ferritin to rule out concurrent iron deficiency before attributing findings solely to thalassemia trait, as recommended by the Centers for Disease Control and Prevention 1, 2